Hypertensive women who were prescribed angotensin receptor blockers were 93% more likely to develop new-onset diabetes compared with those who received angiotensin-converting-enzyme inhibitors, a study in the Journal of Clinical Hypertension revealed. More study is needed but the findings may aid in decision-making among clinicians, the lead researcher said.

Related Summaries